To modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes.

HR 10544 (119th Congress) is federal legislation introduced in the U.S. House of Representatives on September 24, 2026. Current status: Referred to the House Committee on Energy and Commerce. (2026-09-24).